H Kemona
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis
Papers in
-
- Cell Adhesion Molecules Research 10
- Parasitology 10
- Toxoplasma gondii Research Studies 7
- Co-authors
- Violetta Dymicka-PiekarskaJoanna KamińskaOlga Martyna Koper‐LenkiewiczJoanna Matowicka-KarnaPiotr RadziwonJ ProkopowiczJoanna OsadaMariusz Gryko
In The Last Decade
H Kemona
92 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Internal Medicine 119
- Oncology 633
- Parasitology 136
- Hematology 194
- Immunology 317
Countries citing papers authored by H Kemona
This map shows the geographic impact of H Kemona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Kemona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Kemona more than expected).
Fields of papers citing papers by H Kemona
This network shows the impact of papers produced by H Kemona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Kemona. The network helps show where H Kemona may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H Kemona, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 11 | |
| 2 | 2018 | 146 | |
| 3 | 2016 | 47 | |
| 4 | 2015 | 8 | |
| 5 | 2015 | 35 | |
| 6 | 2014 | 49 | |
| 7 | 2014 | 8 | |
| 8 | 2013 | 6 | |
| 9 | Assessment of the levels of nitric oxide (NO) and cytokines (IL-5, IL-6, IL-13, TNF, IFN-gamma) in giardiosis | 2011 | 1 |
| 10 | 2011 | 11 | |
| 11 | 2011 | 42 | |
| 12 | 2011 | 50 | |
| 13 | 2011 | 9 | |
| 14 | 2009 | 21 | |
| 15 | [Platelets activation in depending on glycaemic control in diabetes type 2]. | 2008 | 3 |
| 16 | 2007 | 7 | |
| 17 | 2006 | 34 | |
| 18 | [Usefulness of C-reactive protein (CRP) detection for early diagnosis of infectious postoperative complications after gynecologic surgery]. | 1997 | 2 |
| 19 | [Proteases and protease antagonists in neoplasms]. | 1991 | 1 |
| 20 | Bactericidal activity of blood platelets: its determination and normal values. | 1986 | 2 |
About H Kemona
H Kemona is a scholar working on Immunology and Allergy, Parasitology, Hematology, Oncology and Internal Medicine, having authored 94 papers that have together received 1.9k indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (30 papers), Platelet Disorders and Treatments (14 papers), Cell Adhesion Molecules Research (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Toxoplasma gondii Research Studies (7 papers), Blood properties and coagulation (6 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). The work is most often cited by research in Internal Medicine (119 citations), Oncology (633 citations), Parasitology (136 citations), Hematology (194 citations) and Immunology (317 citations). H Kemona has collaborated with scholars based in Poland, Germany and Austria. Frequent co-authors include Violetta Dymicka-Piekarska, Joanna Kamińska, Olga Martyna Koper‐Lenkiewicz, Joanna Matowicka-Karna, Piotr Radziwon, J Prokopowicz, Joanna Osada, Mariusz Gryko, Katarzyna Guzińska-Ustymowicz and Jerzy Bychowski. Their work appears in journals such as Thrombosis Research, Platelets, Oncotarget, Biomarkers and Advances in Clinical and Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.